CRO

WVU jumps on CRO bandwagon; PSI signs on for Synta's Phase III;

> Following a trend among major research universities, West Virginia University is launching a CRO of its own. Article

> PSI CRO has signed on to conduct Phase III trials of ganetespib, a lung cancer drug under development by Synta Pharmaceuticals. Release

> WuXi PharmaTech ($WX) is expanding its deal with Open Monoclonal Technology to use its transgenic rat models for drug development. Story

> Marken has opened a new GMP-compliant facility in Beijing, expanding its clinical trial supply capabilities. News

> Pharma supplier Ashland is expanding its contract manufacturing business in Delaware to meet client demand. Report